Immunotherapy plus chemo shows promise against tough throat cancer
NCT ID NCT05340270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests whether adding a PD-1 inhibitor (a type of immunotherapy) to standard chemotherapy before radiation can improve outcomes for people with advanced nasopharyngeal carcinoma. About 150 participants will receive either the combination or chemotherapy alone, followed by standard chemoradiation. The main goal is to see if the combination delays cancer progression or death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PD-1 inhibitor (a type of immunotherapy) plus gemcitabine and cisplatin chemotherapy
- What this could lead to
- If successful, this combination could become a new standard approach to shrink advanced nasopharyngeal tumors before radiation, potentially improving long-term survival.
- What could go wrong
- This is a mid-stage trial with only 150 participants, so results may not apply to all patients. Adding immunotherapy also raises the risk of immune-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Could adding extra chemo before standard therapy beat nasopharyngeal cancer?
- Can a triple threat of drug, immunotherapy, and radiation wipe out High-Risk urinary tract cancer before surgery?
- Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining
- Smart T-Cell engager aims to outsmart tumors in first human test
- Could a Triple-Drug attack before surgery eliminate more breast cancer in older women?